Stewart Campbell

Executive Vice President, President, North America

Stewart Campbell was appointed Executive Vice President and President of North America in November 2021.

Stewart joined Ipsen as Senior Vice President and Franchise Head of Oncology in May 2021 from Roche/Genentech where he spent more than 14 years, responsible for the lifecycle management of some of Roche’s oncology blockbusters, including both commercial and clinical development globally. Through a career of more than 20 years in the pharmaceutical industry, Stewart has deep experience leading country and global commercial functions in oncology and specialty care markets, including Canada, Switzerland, and the United States.

Stewart is a graduate of Concordia University in Montreal, Canada, where he received his B.S. in physiology with a minor in physics. He received his MBA in corporate finance from Queens University in Kingston, Canada and an additional MBA in business strategy from the Johnson School of Management at Cornell University in Ithaca, New York.

Our mission?

To improve patients’ lives

Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care. We help patients through our expertise in oncology, neuroscience, and rare disease.

Find out more about us or see other members of our leadership team.

About

Products and partnerships

Our products

Our mission is to improve patients’ lives.

See our products

Partnering

Access our development and commercialization teams. We take bold steps to translate your science and innovations into solutions that make a difference for patients in need.

See more on partnering

Products and partnerships

What’s happening now?

See the latest
©2022 Ipsen Biopharmaceuticals, Inc. NON-US-003140 April 2022